U.S. full prescribing information for Complera is available at www.Complera.com U.S. full prescribing information for Atripla is available at www.Atripla.com U.S. full prescribing information for Truvada is available at www.Truvada.com
EU Summary of Product Characteristics for Atripla, Eviplera and Truvada are available at www.ema.europa.eu
Complera, Eviplera and Truvada are registered trademarks of Gilead Sciences, Inc.
Atripla is a registered trademark of Bristol-Myers Squibb & Gilead Sciences, LLC.Edurant is a registered trademark of Janssen R&D Ireland. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com , follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts